Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02098616 · ClinicalTrials.gov registry record · NA

Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus

A NA study of Hepatitis C, sponsored by Timothy Morgan, MD.

Completed
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT02098616 is a NA study of Hepatitis C that has completed, run by Timothy Morgan, MD. The registered enrollment target is 25 participants, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02098616, a NA study of Hepatitis C, has completed, sponsored by Timothy Morgan, MD.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether treatment with Daclatasvir/Asunaprevir/BMS-791325, with or without ribavirin, for 8, 6, or 4 weeks is feasible for the treatment of genotype 1a chronic hepatitis C in patients without cirrhosis.

Conditions Studied

Hepatitis C

Interventions

  • DRUG DCV/ASV/BMS-791325
  • DRUG DCV/ASV/BMS-791325 + RBV

Study Locations (1)

California

  • VA Long Beach Healthcare System - Long Beach

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2014-07
Est. Completion 2016-02
Phase NA

Sponsor

Timothy Morgan, MD

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02098616

The ClinicalTrials.gov registry entry for NCT02098616 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (99% lower). The listed sponsor is Timothy Morgan, MD, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 2 interventions - of which DCV/ASV/BMS-791325 is the first listed.

NCT02098616 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02098616 about?

NCT02098616 is a clinical study titled "Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus". The purpose of this study is to determine whether treatment with Daclatasvir/Asunaprevir/BMS-791325, with or without ribavirin, for 8, 6, or 4 weeks is feasible for the treatment of genotype 1a chronic hepatitis C in patients without cirrhosis.

What is the current status of trial NCT02098616?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2014-07. Estimated completion is 2016-02.

What conditions does trial NCT02098616 study?

This clinical trial studies the following conditions: Hepatitis C.

What interventions are being tested in trial NCT02098616?

The interventions under investigation include: DCV/ASV/BMS-791325 (DRUG), DCV/ASV/BMS-791325 + RBV (DRUG).

Who is sponsoring clinical trial NCT02098616?

This trial is sponsored by Timothy Morgan, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02098616 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hepatitis C

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.